Skip to main content

ARID1A Mutation in Uterine Corpus Endometrial Carcinoma

Tumor Suppressor

ARID1A mutations occur in approximately 44% of Uterine Corpus Endometrial Carcinoma cases. Explore survival impact, morphological differences, and co-occurring mutations below.